Skip to content
Clinical Trials – home

ACE Inhibitors, Plain: A Comprehensive Guide for Patients

2 / 2
trials open to patients / all trials
13+
Countries

In short

This article discusses recent clinical trials investigating the use of ACE inhibitors, a class of medications commonly used to treat high blood pressure and heart conditions. These trials focus on the role of ACE inhibitors in managing heart failure with recovered heart function and IgA nephropathy, a kidney disorder. The studies aim to evaluate the safety, efficacy, and long-term effects of ACE inhibitors in combination with other treatments for these conditions.

What are ACE Inhibitors?

ACE inhibitors, or Angiotensin-Converting Enzyme inhibitors, are a class of medications primarily used to treat cardiovascular conditions. The term "plain" in "ACE inhibitors, plain" refers to the fact that these medications contain only the ACE inhibitor as the active ingredient, without any additional compounds.

Medical Uses

ACE inhibitors are prescribed for various cardiovascular conditions, including:

  • Heart Failure: They help improve heart function in patients with reduced left ventricular ejection fraction (LVEF).
  • High Blood Pressure (Hypertension): ACE inhibitors are effective in lowering blood pressure.
  • Kidney Protection: They may help slow the progression of kidney disease, especially in patients with diabetes or high blood pressure.
  • Post-Heart Attack Recovery: ACE inhibitors can improve outcomes for patients who have had a heart attack.

How They Work

ACE inhibitors work by blocking the action of the angiotensin-converting enzyme. This enzyme is responsible for producing angiotensin II, a hormone that narrows blood vessels. By inhibiting this enzyme, ACE inhibitors help:

  • Relax and widen blood vessels, improving blood flow
  • Decrease the workload on the heart
  • Lower blood pressure
  • Improve the pumping efficiency of the heart in heart failure patients

Administration

ACE inhibitors are typically taken orally, usually in the form of tablets or capsules. The dosage and frequency can vary depending on the specific medication and the patient's condition. It's important to take ACE inhibitors exactly as prescribed by your healthcare provider.

Potential Side Effects

While ACE inhibitors are generally well-tolerated, they can cause some side effects. Common side effects may include:

  • Dry cough
  • Dizziness
  • Headache
  • Fatigue
  • Elevated potassium levels in the blood

In rare cases, more serious side effects can occur, such as angioedema (swelling of the face, lips, tongue, or throat). If you experience any severe side effects, contact your healthcare provider immediately.

Precautions and Considerations

Before starting ACE inhibitor therapy, it's important to consider the following:

  • Pregnancy: ACE inhibitors can cause harm to the developing fetus and should not be used during pregnancy.
  • Kidney Function: Your doctor will monitor your kidney function, as ACE inhibitors can affect kidney performance.
  • Potassium Levels: Regular blood tests may be necessary to check potassium levels, as ACE inhibitors can increase potassium in the blood.
  • Other Medications: Inform your doctor about all medications you're taking, as ACE inhibitors can interact with certain drugs.

Ongoing Research

Research on ACE inhibitors continues to explore their potential benefits and optimal use. For example, a current study is investigating the effects of discontinuing beta-blockers in heart failure patients with recovered left ventricular ejection fraction who are also on ACE inhibitors or similar medications. This research aims to better understand the long-term management of heart failure patients and may provide insights into the role of ACE inhibitors in maintaining heart health.

Another ongoing study is examining the long-term safety and efficacy of a medication called iptacopan in patients with IgA nephropathy, a kidney disease. In this study, patients are required to be on a stable dose of ACE inhibitors or similar medications as part of their standard care. This research may provide further information on how ACE inhibitors work in combination with newer treatments for kidney diseases.

These studies highlight the continued importance of ACE inhibitors in cardiovascular and kidney health management, as well as the ongoing efforts to optimize their use in various medical conditions.

Questions people often ask

Conditions where Ace Inhibitors, Plain is being studied

Each condition opens its own overview and trial list

Trials with Ace Inhibitors, Plain

Recruiting trials first

See all 2 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).